General Biologicals Corporation 4117.TWO Stock
General Biologicals Corporation Price Chart
General Biologicals Corporation 4117.TWO Financial and Trading Overview
| General Biologicals Corporation stock price | 21.15 TWD |
| Previous Close | 25.1 TWD |
| Open | 25.5 TWD |
| Bid | 24.5 TWD x 0 |
| Ask | 24.95 TWD x 0 |
| Day's Range | 24.6 - 25.5 TWD |
| 52 Week Range | 18.5 - 32.7 TWD |
| Volume | 69.83K TWD |
| Avg. Volume | 104.26K TWD |
| Market Cap | 1.48B TWD |
| Beta (5Y Monthly) | 1.753767 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.71 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4117.TWO Valuation Measures
| Enterprise Value | 1.49B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.9887748 |
| Price/Book (mrq) | 2.1400106 |
| Enterprise Value/Revenue | 4.023 |
| Enterprise Value/EBITDA | -65.691 |
Trading Information
General Biologicals Corporation Stock Price History
| Beta (5Y Monthly) | 1.753767 |
| 52-Week Change | -18.24% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 32.7 TWD |
| 52 Week Low | 18.5 TWD |
| 50-Day Moving Average | 26.11 TWD |
| 200-Day Moving Average | 25.14 TWD |
4117.TWO Share Statistics
| Avg. Volume (3 month) | 104.26K TWD |
| Avg. Daily Volume (10-Days) | 129.02K TWD |
| Shares Outstanding | 59.83M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -14.35% |
| Operating Margin (ttm) | -11.032% |
| Gross Margin | 46.38% |
| EBITDA Margin | -6.12% |
Management Effectiveness
| Return on Assets (ttm) | -1.81% |
| Return on Equity (ttm) | -7.53% |
Income Statement
| Revenue (ttm) | 370.46M TWD |
| Revenue Per Share (ttm) | 6.19 TWD |
| Quarterly Revenue Growth (yoy) | -38.29% |
| Gross Profit (ttm) | N/A |
| EBITDA | -22686000 TWD |
| Net Income Avi to Common (ttm) | -53192000 TWD |
| Diluted EPS (ttm) | -0.88 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 351.08M TWD |
| Total Cash Per Share (mrq) | 5.87 TWD |
| Total Debt (mrq) | 468.82M TWD |
| Total Debt/Equity (mrq) | 67.64 TWD |
| Current Ratio (mrq) | 5.62 |
| Book Value Per Share (mrq) | 11.542 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 224.59M TWD |
| Levered Free Cash Flow (ttm) | -291824992 TWD |
Profile of General Biologicals Corporation
| Country | Taiwan |
| State | N/A |
| City | Hsinchu City |
| Address | No. 6, Innovation First Road |
| ZIP | 30076 |
| Phone | 886 3 577 9221 |
| Website | https://www.gbc.com.tw |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
General Biologicals Corporation engages in manufacturing and selling in-vitro diagnostic devices and pharmaceuticals in Taiwan and internationally. It offers real-time PCR products, including IVD kits and genesis products for breast cancer; ELISA Products comprising KIWI products; RIA products for gastrin, hepatitis, and thyroid, as well as vitamin products; rapid tests consisting of blood glucose monitoring systems, and cardiac and tumor markers, as well as products related to drug abuse, fertility hormones, and infectious diseases; lab ware products; and raw materials that comprise antibodies and antigens. The company also provides protein drugs for oral candidiasis; and point of care products for liver fibrosis and breast cancer indications. In addition, it offers products for use in clinics and laboratories for preventives and cancer diagnosis, including skin and oral care, breast cancer and liver related, and advanced cancer diagnosis products, as well as healthcare and education services. General Biologicals Corporation was founded in 1984 and is headquartered in Hsinchu City, Taiwan.
Q&A For General Biologicals Corporation Stock
What is a current 4117.TWO stock price?
General Biologicals Corporation 4117.TWO stock price today per share is 21.15 TWD.
How to purchase General Biologicals Corporation stock?
You can buy 4117.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for General Biologicals Corporation?
The stock symbol or ticker of General Biologicals Corporation is 4117.TWO.
Which industry does the General Biologicals Corporation company belong to?
The General Biologicals Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does General Biologicals Corporation have in circulation?
The max supply of General Biologicals Corporation shares is 59.82M.
What is General Biologicals Corporation Price to Earnings Ratio (PE Ratio)?
General Biologicals Corporation PE Ratio is now.
What was General Biologicals Corporation earnings per share over the trailing 12 months (TTM)?
General Biologicals Corporation EPS is -2.71 TWD over the trailing 12 months.
Which sector does the General Biologicals Corporation company belong to?
The General Biologicals Corporation sector is Healthcare.